The spectrum of psychiatric symptoms in Wilson's disease: treatment and prognostic considerations

Am J Psychiatry. 2015 Nov 1;172(11):1068-72. doi: 10.1176/appi.ajp.2015.15030371.

Authors

Paula C Zimbrean¹, Michael L Schilsky¹

Affiliation

¹ From the Departments of Psychiatry and Internal Medicine, Yale University School of Medicine, and the Wilson Disease Center for Excellence, Yale University Medical Center, New Haven, Conn.

PMID: 26575449
DOI: 10.1176/appi.ajp.2015.15030371

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antidepressive Agents / therapeutic use
Antipsychotic Agents / therapeutic use
Capgras Syndrome / drug therapy
Capgras Syndrome / etiology
Capgras Syndrome / psychology*
Chelating Agents / therapeutic use
Depressive Disorder / drug therapy
Depressive Disorder / etiology
Depressive Disorder / psychology*
Disease Progression
Female
Hepatolenticular Degeneration / complications
Hepatolenticular Degeneration / drug therapy
Hepatolenticular Degeneration / psychology*
Humans
Prognosis
Psychotic Disorders / drug therapy
Psychotic Disorders / etiology
Psychotic Disorders / psychology*
Trace Elements / therapeutic use
Trientine / therapeutic use
Zinc / therapeutic use

Substances

Antidepressive Agents
Antipsychotic Agents
Chelating Agents
Trace Elements
Zinc
Trientine